Schroder Investment Management Group »

Summit Therapeutics shares owned by Schroder Investment Management Group

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Schroder Investment Management Group from 13F filings

Historical chart of Schroder Investment Management Group investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Schroder Investment Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Schroder Investment Management Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.1M 243k 21.16
2025-06-30 $3.1M 145k 21.28
2025-03-31 $4.7M 234k 20.32